Mary Mirabelli Buys Shares of GNLX

On June 16, 2026, Mary Mirabelli bought 31,566 shares of GNLX. This insider transaction did not involve a pre-planned trading agreement. The stock was trading near $2.97 at the time.

Insider Buying and Selling at Genelux Corporation

Alongside Mary Mirabelli, several other insiders, including John Smither, James Tyree, and Chief Scientific Officer Yong Yu, also acquired shares on the same day. Each insider purchased 31,566 shares, except for Yong Yu, who bought 119,318 shares. None of these transactions were part of a pre-planned trading plan.

Other Institutional Activity in GNLX

Several institutional investors have been active in GNLX recently. Woodward Diversified Capital, LLC increased its holdings by 184,472 shares, reaching a total of 2,117,183 shares valued at approximately $5.91 million. Vanguard Capital Management LLC made a significant move by acquiring 1,695,480 shares, bringing its total to the same amount, with a value of about $4.10 million. Bleichroeder LP also boosted its position by 666,666 shares, now holding 1,380,666 shares worth $3.34 million. Geode Capital Management, LLC and BlackRock, Inc. added 72,354 and 20,564 shares, respectively, with total holdings valued at $1.10 million and $982,210.

Analysts Set New Price Targets

On March 20, 2026, Benchmark maintained its 'buy' rating for GNLX, setting a price target of $20. Lake Street had previously initiated coverage with a 'buy' rating and a $16 price target on October 21, 2025. Lucid Capital Markets also initiated a 'buy' rating with a $10 price target on July 21, 2025. Overall, the consensus among analysts is a 'buy' rating, reflecting strong optimism about the company's future prospects.

Bottom Line

Mary Mirabelli's recent purchase of GNLX shares highlights ongoing insider interest in the company. Institutional investors have also been adjusting their positions, reflecting varied perspectives on GNLX's potential. Analysts maintain a positive outlook, with several firms reiterating 'buy' ratings and setting ambitious price targets. Investors typically track insider and institutional activity for insights into a company's potential, although these transactions are reported after they occur.